Ban on drug advertising related with PPA ingredient

The KPMA's Preview Committee for Pharmaceutical Advertising notified all member companies not to do any drug advertising by quoting PPA (Phenylpropanolamine: a sympathomimetic agent) ingredient, which is found in dozens of remedies and is linked to very rare cases of strokes in adults, particularly women under age 50.

The Committee has previously regulated other similar cases, expressing "N...